Figure 4From: Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial Estimated change in CAARS:O-SV score over time by treatment group for given levels of adherence. Back to article page